This study explores the effects of anisodamine-tirofiban combined therapy on cardiac function and the expression of serum NGF and ESM-1 in patients with acute myocardial infarction who underwent percutaneous intervention (PCI), to provide a scientific basis for clinical treatment. The gene discussed is NGF; the disease is myocardial infarction.